INTEGRA LIFESCIENCES HOLDINGS CORPORATION

Analyst Reco. Integra LifeSciences Holdings Corporation

Equities

IART

US4579852082

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
30.9 ^USD	+0.32%		+9.15%	-29.05%

May. 24	Integra Lifesciences Holdings Insider Bought Shares Worth $1,499,979, According to a Recent SEC Filing	MT
May. 22	Integra Lifesciences Holdings Insider Bought Shares Worth $995,816, According to a Recent SEC Filing	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Integra Lifesciences Holdings Insider Bought Shares Worth $1,499,979, According to a Recent SEC Filing	May. 24	MT
Integra Lifesciences Holdings Insider Bought Shares Worth $995,816, According to a Recent SEC Filing	May. 22	MT
Truist Cuts Price Target on Integra LifeSciences Holdings to $25 From $37, Keeps Hold Rating	May. 07	MT
Wells Fargo Downgrades Integra LifeSciences Holdings to Equalweight From Overweight, Cuts Price Target to $25 From $45	May. 07	MT
Oppenheimer Downgrades Integra LifeSciences Holdings to Perform From Outperform	May. 07	MT
North American Morning Briefing : Stock Futures -2-	May. 06	DJ
Citigroup Upgrades Integra LifeSciences to Neutral From Sell With $38 Price Target	Apr. 03	MT
Citigroup Upgrades Integra LifeSciences to Neutral From Sell, Price Target is $38	Apr. 03	MT
Truist Securities Cuts Price Target on Integra LifeSciences Holdings to $41 From $46, Maintains Hold Rating	Mar. 01	MT
Truist Securities Adjusts Price Target on Integra LifeSciences to $46 From $44, Maintains Hold Rating	Dec. 22	MT
Truist Adjusts Integra LifeSciences Holdings' Price Target to $44 From $39, Keeps Hold Rating	Dec. 14	MT
Wells Fargo Upgrades Integra LifeSciences to Overweight From Equalweight, Raises Price Target to $49 From $40	Dec. 05	MT
CL King Starts Coverage on Integra LifeSciences With Buy Rating, $50 Price Target	Nov. 14	MT
Morgan Stanley Adjusts Price Target on Integra LifeSciences to $37 From $44, Maintains Underweight Rating	23-10-26	MT
Morgan Stanley Downgrades Integra LifeSciences to Underweight From Equalweight, Price Target is $44	23-08-24	MT
JMP Securities Adjusts Integra LifeSciences Price Target to $60 From $65, Maintains Market Outperform Rating	23-07-28	MT
Truist Securities Adjusts Price Target on Integra LifeSciences to $48 From $44, Maintains Hold Rating	23-07-19	MT
Is it game over for inflation?	23-07-12
Jefferies Upgrades Integra LifeSciences to Buy From Hold, Cuts Price Target to $53 From $58	23-07-12	MT
ANALYST RECOMMENDATIONS : Activision Blizzard, AstraZeneca, Citigroup, Microsoft, Model N...	23-07-12

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Integra LifeSciences Holdings Corporation

Equities

IART

US4579852082

Analyst Reco.

Filters